癌の発症と進行におけるストロマル線維芽細胞
Neil A Bhowmick1, Eric G Neilson, Harold L Moses
1Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.
Nature
|November 19, 2004
まとめ
腫瘍のマイクロ環境にある細胞であるフィブロブラストは,癌の発達と進行に大きく影響する. その役割を理解することで,この一般的なヒトがんに対する新たな治療戦略が生まれます.
科学分野:
- 腫瘍学 腫瘍学
- がん生物学 がん生物学
- 細胞生物学 細胞生物学
背景:
- 人間に最も一般的な癌であるがんは,上皮細胞の蓄積された体内変異から生じます.
- 細胞外マトリックス,血管系,炎症細胞,および線維芽細胞を含む腫瘍の微環境は,癌の行動に影響します.
- 線維芽細胞は,がんの発達と進行における重要な役割としてますます認識されています.
研究 の 目的:
- 癌発症にフィブロブラストが及ぼす重大な影響を強調する.
- 癌の進行における腫瘍の微小環境の重要性を強調するために.
- 癌におけるフィブロブラストの役割の治療的影響について議論する.
主な方法:
- 癌における線維細胞の機能に関する最近の科学文献のレビュー.
- 腫瘍の微小環境ががんに与える影響を調査する研究分析.
- 線維芽細胞癌の相互作用に関する発見の統合.
主要な成果:
- 繊維芽細胞は,これまで考えられていたよりも,がんの発症により大きな影響を及ぼします.
- 腫瘍の微小環境,特に線維芽細胞は,がんの進行において重要な役割を果たします.
- 新興の研究は,腫瘍発生にフィブロブラストの多面的な貢献を強調しています.
結論:
- 繊維芽細胞は,がんの発達と進行において重要な役割を果たします.
- 腫瘍の微小環境内の線維芽細胞を標的とした治療は,有望な治療の道を示しています.
- 線維芽細胞癌の相互作用に関するさらなる研究は,がん治療の進歩に不可欠です.
さらに関連する動画
09:52A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
Published on: September 20, 2016
06:35A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth
Published on: December 22, 2020
関連する概念動画
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Introduction to Fibroblasts
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
